N-acetylcysteine modulates glutamatergic dysfunction and depressive behavior in Huntington's disease.

about

Protective Effect of Antioxidants on Neuronal Dysfunction and Plasticity in Huntington's Disease.Huntington's Disease: Pathogenic Mechanisms and Therapeutic Targets.Antidepressant Effects of Probucol on Early-Symptomatic YAC128 Transgenic Mice for Huntington's Disease

P2860

Q37607467-08A97460-38C7-4CD2-979E-FE2BE3A85AB1 Q38663090-6148B84B-7ADF-4D72-8705-4B7CCD92D84E Q58780496-9BF7DCD8-8081-4136-A7FB-AF4D36C44A49

P2860

N-acetylcysteine modulates glutamatergic dysfunction and depressive behavior in Huntington's disease.

Item

http://www.wikidata.org/entity/Q45295137

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

N-acetylcysteine modulates glu ...... avior in Huntington's disease.

@en

N-acetylcysteine modulates glu ...... avior in Huntington's disease.

@nl

type

Item

label

N-acetylcysteine modulates glu ...... avior in Huntington's disease.

@en

N-acetylcysteine modulates glu ...... avior in Huntington's disease.

@nl

prefLabel

N-acetylcysteine modulates glu ...... avior in Huntington's disease.

@en

N-acetylcysteine modulates glu ...... avior in Huntington's disease.

@nl

P1476

N-acetylcysteine modulates glu ...... havior in Huntington's disease

@en

P2093

David Pow

http://www.w3.org/2001/XMLSchema#string

Dean J Wright

http://www.w3.org/2001/XMLSchema#string

Laura J Gray

http://www.w3.org/2001/XMLSchema#string

Paul S Francis

http://www.w3.org/2001/XMLSchema#string

Shanshan Li

http://www.w3.org/2001/XMLSchema#string

Thibault Renoir

http://www.w3.org/2001/XMLSchema#string

P2860

Using glutamate homeostasis as a target for treating addictive disorders

Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders

Astrocyte pathology in major depressive disorder: insights from human postmortem brain tissue

Thinking outside the cleft to understand synaptic activity: contribution of the cystine-glutamate antiporter (System xc-) to normal and pathological glutamatergic signaling

Redox outside the box: linking extracellular redox remodeling with intracellular redox metabolism

Glutamate uptake

Depression: a new animal model sensitive to antidepressant treatments

N-Acetylcysteine improves mitochondrial function and ameliorates behavioral deficits in the R6/1 mouse model of Huntington's disease

Decreased expression of synapse-related genes and loss of synapses in major depressive disorder

Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice

P304

2923-2933

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/HMG/DDW144

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-05-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27179791

http://www.w3.org/2001/XMLSchema#string

P921

Huntington disease

N-acetylcysteine modulates glutamatergic dysfunction and depressive behavior in Huntington's disease.

about

P2860

P2860

N-acetylcysteine modulates glutamatergic dysfunction and depressive behavior in Huntington's disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921